What does “isosorbide dinitrate patent” usually mean?
People typically ask this when they want to know whether the drug is still protected by a patent (so generic manufacturers might be blocked) or if patents are expired (so generic versions can compete). With established medicines like isosorbide dinitrate, the more common situation is that older formulation or method-of-use patents have expired, leaving generics to supply the market.
Isosorbide dinitrate still under patent protection?
I don’t have enough provided information to confirm the current patent status (active vs. expired) for isosorbide dinitrate specifically. Patent status depends on the exact product type (for example, immediate-release vs. extended-release), the manufacturer, and which patent family is being asked about.
How can you check patent status quickly for isosorbide dinitrate?
A practical way is to search the drug and filter to see whether any patents are listed as active, expired, or in litigation. DrugPatentWatch.com is commonly used for this purpose, and you can search directly on their site: DrugPatentWatch – Isosorbide Dinitrate.
Why patent status matters for patients and pricing
If patents covering a specific isosorbide dinitrate product are expired, multiple generic manufacturers can usually sell it, which tends to lower cost and expand availability. If some patents are still active for a particular formulation or dosing design, that can limit generic competition for that specific version, even if other versions are widely generic.
Quick clarifying question to get an exact answer
Which “isosorbide dinitrate” are you asking about—tablet (immediate-release), extended-release, or a specific brand name/manufacturer? If you share the exact product (or NDC), I can narrow the patent look-up to the right patent family and explain what’s protecting it.
Sources
- DrugPatentWatch – Isosorbide Dinitrate